Détails du produit
Synonyms
NECTIN4, LNIR, PRR4, PVRL4
Source
PE-Labeled Human Nectin-4 Protein, His Tag (NE4-HP2H4) is produced via site-specific conjugation of PE to Human Nectin-4 Protein, His Tag under optimal conditions with a proprietary technology. Human Nectin-4 Protein, His Tag is expressed from human 293 cells (HEK293). It contains AA Gly 32 - Ser 349 (Accession # Q96NY8-1).
Predicted N-terminus: Gly 32
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 37.8 kDa.
Conjugate
PE
Excitation Wavelength: 488 nm / 561 nm
Emission Wavelength: 575 nm
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, 0.5% BSA, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please protect from light and avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Les clients ont également consulté
Affichage des données
Bioactivity-FACS

5e5 of Anti-Nectin-4 CAR-293 cells were stained with 100 μL of 1:25 dilution (4 μL stock solution in 100 μL FACS buffer) of PE-Labeled Human Nectin-4 Protein, His Tag (Cat. No. NE4-HP2H4) and negative control protein respectively. PE signal was used to evaluate the binding activity (QC tested).
Protocol
Avis des utilisateurs Publier un commentaire

Introduction de fond
Progrès de frontière
- Nom anglais:
Nectin-4
- Catégorie:
- Nombre de médicaments répertoriés:
1 Détails
- Nombre de médicaments cliniques:
28 Détails
- Étape de développement la plus élevée:
Approved



















